Kindos creates the new record for fastest approval by FDA: Dacarbazine for Injection
On April 3, 2024, Dacarbazine for Injection of Kindos Pharmaceuticals Co., Ltd.(Subsidiary of Nanjing Kingfriend) got approved for commercial sale by US FDA via conditional accelerated approval.